(S (NP-SBJ (NP Stable/JJ expression/NN) (PP of/IN (NP (NP HB24/NN) ,/, (NP a/DT diverged/JJ human/JJ homeobox/NN gene/NN) ,/,)) (PP in/IN (NP T/NN lymphocytes/NNS))) (VP induces/VBZ (NP (NP genes/NNS) (VP involved/VBN (NP */-NONE-) (PP in/IN (NP T/NN cell/NN (NP-COOD (NP activation/NN) and/CC (NP growth/NN))))))) ./.)
(S (NP-SBJ-53 (NP (NP A/DT diverged/JJ homeobox/NN gene/NN) ,/, (NP HB24/NN)) ,/, (SBAR (WHNP-54 which/WDT) (S (NP-SBJ-55 *T*-54/-NONE-) (VP is/VBZ (VP known/VBN (S (NP-SBJ-56 *-55/-NONE-) (VP to/TO (VP be/VB (VP induced/VBN (NP *-56/-NONE-) (PP-TMP following/VBG (NP lymphocyte/NN activation/NN)))))))))) ,/,) (VP was/VBD (VP introduced/VBN (NP *-53/-NONE-) (PP into/IN (NP Jurkat/NN T/NN cells/NNS)) (PP under/IN (NP (NP the/DT control/NN) (PP of/IN (NP a/DT constitutive/JJ promoter/NN)))))) ./.)
(S (NP-SBJ-57 (NP Stable/JJ transfectants/NNS) (PP of/IN (NP HB24/NN)) (SBAR *ICH*-58/-NONE-)) (VP were/VBD (VP established/VBN (NP *-57/-NONE-) (SBAR-58 (WHNP-59 that/WDT) (S (NP-SBJ *T*-59/-NONE-) (VP-COOD (VP expressed/VBD (NP (NP high/JJ levels/NNS) (PP of/IN (NP HB24/NN mRNA/NN)))) and/CC (VP possessed/VBD (NP (NP an/DT altered/JJ phenotype/NN) (ADJP suggestive/JJ (PP of/IN (NP activated/VBN T/NN cells/NNS)))))))))) ./.)
(S (NP-SBJ-60 (NP A/DT number/NN) (PP of/IN (NP (NP genes/NNS) (VP-COOD (VP known/VBN (S (NP-SBJ-62 */-NONE-) (VP to/TO (VP be/VB (VP induced/VBN (NP *-62/-NONE-) (PP-TMP following/VBG (NP T/NN cell/NN activation/NN))))))) and/CC (VP associated/VBN (NP */-NONE-) (PP with/IN (NP cell/NN growth/NN))))))) (VP were/VBD (VP increased/VBN (NP *-60/-NONE-) (PP in/IN (NP (NP the/DT transfectants/NNS) ,/, (PP including/VBG (NP-COOD (NP c-fos/NN) ,/, (NP c-myc/NN) ,/, (NP c-myb/NN) ,/, (NP HLA-DR/NN) ,/, (NP lck/NN) ,/, (NP NF-kappa/NN B/NN) ,/, (NP interleukin-2/NN) and/CC (NP (NP interleukin-2/NN receptor/NN alpha/NN) (PRN -LRB-/-LRB- (NP IL-2R/NN alpha/NN) -RRB-/-RRB-)))))))) ./.)
(S (NP-SBJ (NP Analysis/NN) (PP of/IN (NP (NP IL-2R/NN alpha/NN expression/NN) (PP by/IN (NP (NP transient/JJ transfection/NN) (PP of/IN (NP IL-2R/NN alpha/NN promoter/NN constructs/NNS)) (PP into/IN (NP the/DT HB24/NN transfectants/NNS))))))) (VP revealed/VBD (NP (NP (NP constitutive/JJ expression/NN) (PRN -LRB-/-LRB- (FRAG (NP (NP (QP about/RB 60/CD) %/NN) (PP of/IN (NP (ADJP-COOD (ADJP (NP phytohemagglutinin-/NN) (ADJP *?*/-NONE-)) and/CC (ADJP phorbol/NN ester-activated/JJ)) Jurkat/NN cells/NNS)))) -RRB-/-RRB-)) (SBAR (WHNP-63 that/WDT) (S (NP-SBJ *T*-63/-NONE-) (VP was/VBD (ADJP-PRD dependent/JJ (PP on/IN (NP (NP the/DT kappa/NN B/NN site/NN) (PP in/IN (NP the/DT IL-2R/NN alpha/NN promoter/NN)))))))))) ./.)
(S (ADVP Furthermore/RB) ,/, (PP as/IN (NP (NP a/DT consequence/NN) (PP of/IN (NP the/DT increased/VBN HB24/NN mRNA/NN levels/NNS)))) ,/, (NP-SBJ the/DT Jurkat/NN HB24/NN transfectants/NNS) (VP proliferated/VBD (ADVP-TMP (ADVP more/RBR rapidly/RB) (PP than/IN (NP control/NN cell/NN lines/NNS)))) ./.)
(S (ADVP Thus/RB) ,/, (NP-SBJ-64 (NP stable/JJ expression/NN) (PP of/IN (NP HB24/NN))) (VP confers/VBZ (NP an/DT activation/NN phenotype/NN) (PP on/IN (NP a/DT human/JJ T/NN cell/NN line/NN)) ,/, (S (NP-SBJ *-64/-NONE-) (VP implicating/VBG (NP this/DT gene/NN) (PP as/IN (NP (NP an/DT important/JJ transcriptional/JJ factor/NN) (PP-TMP during/IN (NP T/NN cell/NN (NP-COOD (NP activation/NN) and/CC (NP growth/NN))))))))) ./.)
